Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00613886 · ClinicalTrials.gov registry record · NA
Factors Predicting Response to Shunting in Normal Pressure Hydrocephalus
A NA study, sponsored by University of California, Irvine.
- Terminated
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT00613886: Clinical Trial NA study, sponsored by University of California, Irvine.
NCT00613886 is a NA study that was terminated before completion, run by University of California, Irvine. The registered enrollment target is 24 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00613886, a NA study, was terminated before completion, sponsored by University of California, Irvine.
- TERMINATED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
The research project is designed to determine which combination of tests will enable physicians to predict whether a patient with symptoms of normal pressure hydrocephalus (NPH) will improve with a shunt.
Primary Outcome
A brain CT scan is obtained after the first week to ten days and the shunt is adjusted according to the patients signs and symptoms. Prior to any downward adjustment of the shunt valve (which allows more CSF drainage), a brain CT is obtained to look for subdural hematoma or effusion. If any type of subdural collection is found, the valve pressure is increased (to reduce CSF flow) until the collection resolves.
Interventions
- DEVICE Programmable Shunt Insertion (Codman, Medtronic)
- BEHAVIORAL Assessments in physical therapy, occupational therapy, and speech therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2006-03 |
| Est. Completion | 2009-04 |
| Phase | NA |
Why NCT00613886 stopped before completion
NCT00613886 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Programmable Shunt Insertion (Codman, Medtronic) is the first listed.
NCT00613886 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00613886 about?
NCT00613886 is a clinical study titled "Factors Predicting Response to Shunting in Normal Pressure Hydrocephalus". The research project is designed to determine which combination of tests will enable physicians to predict whether a patient with symptoms of normal pressure hydrocephalus (NPH) will improve with a shunt.
What is the current status of trial NCT00613886?
This trial is currently terminated. It is a NA study. The enrollment target is 24 participants. The study started on 2006-03. Estimated completion is 2009-04.
What interventions are being tested in trial NCT00613886?
The interventions under investigation include: Programmable Shunt Insertion (Codman, Medtronic) (DEVICE), Assessments in physical therapy, occupational therapy, and speech therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT00613886?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00613886's enrollment target sits among peer trials
24 1736th of 2000 higher than 246 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia